Financial Data and Key Metrics Changes - Total company revenue for Q4 2025 was $539.1 million, a 15.9% increase from $465 million in Q4 2024 [8] - For the full year 2025, revenue reached $2.2 billion, up 13.9% from $1.9 billion in 2024 [9] - Adjusted EBITDA for Q4 2025 was $95.3 million, a 22.9% increase from $77.5 million in Q4 2024 [14] - Adjusted net income attributable to the company was $36.1 million for Q4 2025, compared to $22.2 million in the prior year [16] Business Line Data and Key Metrics Changes - Occupational health center segment revenue was $490.6 million in Q4 2025, a 12.2% increase year-over-year [19] - On-site health clinics segment reported revenue of $36.2 million in Q4 2025, a 112% increase from the same quarter prior year, largely due to the acquisition of Pivot [22] - Other businesses generated revenue of $12.3 million in Q4 2025, a 12.6% increase year-over-year [23] Market Data and Key Metrics Changes - Total patient visits increased 9% to over 51,000 visits per day in Q4 2025 [9] - Workers' compensation visits per day increased 9.1%, while employer service visits increased 9.4% compared to the prior year [10] - The blue-collar economy added over 450,000 net jobs in 2025, growing at a rate of 0.4% [12] Company Strategy and Development Direction - The company plans to continue with smaller bolt-on acquisitions, which are expected to be accretive due to top line and cost synergies [18] - A strong pipeline for de novo openings is anticipated, with targets of 7 to 9 new sites in 2026 [33] - The company is actively monitoring the New York workers' compensation fee schedule for potential expansion opportunities [34] Management's Comments on Operating Environment and Future Outlook - Management remains positive on the long-term outlook for the U.S. labor market, expecting to add 5.2 million jobs from 2024 through 2034 [12] - The company anticipates stable injury incidence rates and an aging workforce will provide strong tailwinds for business growth [13] - Management expressed confidence in achieving the 2026 revenue target of $2.25 billion to $2.35 billion [36] Other Important Information - The company generated $118.7 million in operating cash flow in Q4 2025, an increase from $93.7 million in Q4 2024 [27] - Free Cash Flow for the full year was $197.8 million, with a conversion rate of 114% [29] - A cash dividend of six and a quarter cents per share was declared, payable on March 19, 2026 [39] Q&A Session Summary Question: How are you contemplating weather or potential elevated respiratory activity to start the year? - Management does not anticipate significant impacts from weather or respiratory activity on operations [42][43] Question: Can you walk us through your thought process on evaluating new opportunities for de novos or M&A? - The company closely monitors Return on Invested Capital and has a track record of successful M&A and de novo execution [44][45] Question: Can you provide more detail about the New York opportunity and how quickly you could enter the market? - Management is looking for a comprehensive review of the fee schedule and believes they can move quickly to establish new centers if conditions improve [49][50][53] Question: What is the expected cadence for 2026 and how will de novo investments be spread throughout the year? - The company expects to have a pickup in Q1 from recent acquisitions and plans to spread de novo openings throughout the year [56][58] Question: How is labor retention trending and what type of wage inflation is built into the guide? - Labor trends are normal with wage inflation in the 2%-3% range, and turnover is decreasing, indicating a more stable workforce [66][68] Question: Who are you taking market share from and is this sustainable growth? - The company has developed technologies to capture additional customers and improve retention, supporting sustainable growth [71][72][74]
Concentra Group Holdings Parent, Inc.(CON) - 2025 Q4 - Earnings Call Transcript